Search


Current filters:





Start a new search
Add filters:

Use filters to refine the search results.


Results 31-40 of 79 (Search time: 0.004 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2015TIDEL-II: first-line use of imatinib in CML with early switch to nilotinib for failure to achieve time-dependent molecular targetsYeung, D.; Osborn, M.; White, D.; Branford, S.; Braley, J.; Herschtal, A.; Kornhauser, M.; Issa, S.; Hiwase, D.; Hertzberg, M.; Schwarer, A.; Filshie, R.; Arthur, C.; Kwan, Y.; Trotman, J.; Forsyth, C.; Taper, J.; Ross, D.; Beresford, J.; Tam, C.; et al.
2009Do we know what patients want? The doctor-patient communication gap in functional gastrointestinal disordersCollins, J.; Farrall, E.; Turnbull, D.; Hetzel, D.; Holtmann, G.; Andrews, J.
2012Impact of age on choice of chemotherapy and outcome in advanced colorectal cancerKhattak, M.; Townsend, A.; Beeke, C.; Karapetis, C.; Luke, C.; Padbury, R.; Maddern, G.; Roder, D.; Price, T.
2004Bisphosphonate infusions: patient preference, safety and clinic useChern, B.; Joseph, D.; Joshua, D.; Pittman, K.; Richardson, G.; Schou, M.; Lowe, S.; Copeman, M.; De Abreu Lourenco, R.; Lynch, K.
2007A randomized, comparative study of three doses of AZD0865 and esomeprazole for healing of reflux esophagitisKahrilas, P.; Dent, J.; Lauritsen, K.; Malfertheiner, P.; Denison, H.; Franzen, S.; Hasselgren, G.
2007Response-driven combination therapy with conventional disease-modifying antirheumatic drugs can achieve high response rates in early rheumatoid arthritis with minimal glucocorticoid and nonsteroidal anti-inflammatory drug useProudman, S.; Keen, H.; Stamp, L.; Lee, A.; Goldblatt, F.; Ayres, O.; Rischmueller, M.; James, M.; Hill, C.; Caughey, G.; Cleland, L.
2000Long-term omeprazole treatment in resistant gastroesophageal reflux disease: Efficacy, safety, and influence on gastric mucosaKlinkenberg-Knol, E.; Nelis, F.; Dent, J.; Snel, P.; Mitchell, B.; Prichard, P.; Lloyd, D.; Havu, N.; Frame, M.; Roman, J.; Walan, A.
2006Donor methylenetetrahydrofolate reductase genotype is associated with graft-versus-host disease in hematopoietic stem cell transplant patients treated with methotrexateMurphy, N.; Diviney, M.; Szer, J.; Bardy, P.; Grigg, A.; Hoyt, R.; King, B.; MacGregor, L.; Holdsworth, R.; McCluskey, J.; Tait, B.
2011Efficacy of α-lactalbumin and milk protein on weight loss and body composition during energy restrictionSoenen, S.; Hochstenbach-Waelen, A.; Westerterp-Plantenga, M.
2005Superior outcomes in renal transplantation after early cyclosporine withdrawal and sirolimus maintenance therapy, regardless of baseline renal functionRuss, G.; Segoloni, G.; Oberbauer, R.; Legendre, C.; Mota, A.; Eris, J.; Grinyo, J.; Friend, P.; Lawen, J.; Hartmann, A.; Schena, F.; Lelong, M.; Burke, J.; Neylan, J.